July 26, 2022
Via: Biopharma DiveAgios Pharmaceuticals needed money. It was 2010 and Agios, like many other biotechnology startups then, was trying to survive following a global recession. Venture capital was contracting, leaving emerging companies with fewer financing options. Initial public offerings, a main source of […]
September 21, 2023
September 19, 2023
September 14, 2023
September 7, 2023
September 5, 2023
September 1, 2023
August 30, 2023
September 19, 2023